Elliot J. Glotfelty

机构：National Institute on Drug Abuse · ORCID：0000-0001-5125-8720

发表论文 36 篇 · 总被引 1171 次 · h-index 18

代表论文

• Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment (2022 · Pharmacological Research · 被引 273)
• Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesis (2022 · Alzheimer s & Dementia · 被引 218)
• Glucagon-like peptide-1 (GLP-1)-based receptor agonists as a treatment for Parkinson’s disease (2020 · Expert Opinion on Investigational Drugs · 被引 64)
• The RhoA-ROCK1/ROCK2 Pathway Exacerbates Inflammatory Signaling in Immortalized and Primary Microglia (2023 · Cells · 被引 55)
• The metabolite GLP‐1 (9‐36) is neuroprotective and anti‐inflammatory in cellular models of neurodegeneration (2021 · Journal of Neurochemistry · 被引 46)
• Neuronal delivery of antibodies has therapeutic effects in animal models of botulism (2021 · Science Translational Medicine · 被引 45)